Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy.
Developing patient derived models from individual tumors that capture the biological heterogeneity and mutation landscape in advanced prostate cancer is challenging, but essential for understanding tumor progression and delivery of personalized therapy in metastatic castrate resistant prostate cance...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0145176&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850189442471428096 |
|---|---|
| author | Manish Kohli Liguo Wang Fang Xie Hugues Sicotte Ping Yin Scott M Dehm Steven N Hart Peter T Vedell Poulami Barman Rui Qin Douglas W Mahoney Rachel E Carlson Jeanette E Eckel-Passow Thomas D Atwell Patrick W Eiken Brendan P McMenomy Eric D Wieben Gautam Jha Rafael E Jimenez Richard Weinshilboum Liewei Wang |
| author_facet | Manish Kohli Liguo Wang Fang Xie Hugues Sicotte Ping Yin Scott M Dehm Steven N Hart Peter T Vedell Poulami Barman Rui Qin Douglas W Mahoney Rachel E Carlson Jeanette E Eckel-Passow Thomas D Atwell Patrick W Eiken Brendan P McMenomy Eric D Wieben Gautam Jha Rafael E Jimenez Richard Weinshilboum Liewei Wang |
| author_sort | Manish Kohli |
| collection | DOAJ |
| description | Developing patient derived models from individual tumors that capture the biological heterogeneity and mutation landscape in advanced prostate cancer is challenging, but essential for understanding tumor progression and delivery of personalized therapy in metastatic castrate resistant prostate cancer stage. To demonstrate the feasibility of developing patient derived xenograft models in this stage, we present a case study wherein xenografts were derived from cancer metastases in a patient progressing on androgen deprivation therapy and prior to initiating pre-chemotherapy enzalutamide treatment. Tissue biopsies from a metastatic rib lesion were obtained for sequencing before and after initiating enzalutamide treatment over a twelve-week period and also implanted subcutaneously as well as under the renal capsule in immuno-deficient mice. The genome and transcriptome landscapes of xenografts and the original patient tumor tissues were compared by performing whole exome and transcriptome sequencing of the metastatic tumor tissues and the xenografts at both time points. After comparing the somatic mutations, copy number variations, gene fusions and gene expression we found that the patient's genomic and transcriptomic alterations were preserved in the patient derived xenografts with high fidelity. These xenograft models provide an opportunity for predicting efficacy of existing and potentially novel drugs that is based on individual metastatic tumor expression signature and molecular pharmacology for delivery of precision medicine. |
| format | Article |
| id | doaj-art-ee4f5577a1824151b4e6d9279e900ea5 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-ee4f5577a1824151b4e6d9279e900ea52025-08-20T02:15:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014517610.1371/journal.pone.0145176Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy.Manish KohliLiguo WangFang XieHugues SicottePing YinScott M DehmSteven N HartPeter T VedellPoulami BarmanRui QinDouglas W MahoneyRachel E CarlsonJeanette E Eckel-PassowThomas D AtwellPatrick W EikenBrendan P McMenomyEric D WiebenGautam JhaRafael E JimenezRichard WeinshilboumLiewei WangDeveloping patient derived models from individual tumors that capture the biological heterogeneity and mutation landscape in advanced prostate cancer is challenging, but essential for understanding tumor progression and delivery of personalized therapy in metastatic castrate resistant prostate cancer stage. To demonstrate the feasibility of developing patient derived xenograft models in this stage, we present a case study wherein xenografts were derived from cancer metastases in a patient progressing on androgen deprivation therapy and prior to initiating pre-chemotherapy enzalutamide treatment. Tissue biopsies from a metastatic rib lesion were obtained for sequencing before and after initiating enzalutamide treatment over a twelve-week period and also implanted subcutaneously as well as under the renal capsule in immuno-deficient mice. The genome and transcriptome landscapes of xenografts and the original patient tumor tissues were compared by performing whole exome and transcriptome sequencing of the metastatic tumor tissues and the xenografts at both time points. After comparing the somatic mutations, copy number variations, gene fusions and gene expression we found that the patient's genomic and transcriptomic alterations were preserved in the patient derived xenografts with high fidelity. These xenograft models provide an opportunity for predicting efficacy of existing and potentially novel drugs that is based on individual metastatic tumor expression signature and molecular pharmacology for delivery of precision medicine.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0145176&type=printable |
| spellingShingle | Manish Kohli Liguo Wang Fang Xie Hugues Sicotte Ping Yin Scott M Dehm Steven N Hart Peter T Vedell Poulami Barman Rui Qin Douglas W Mahoney Rachel E Carlson Jeanette E Eckel-Passow Thomas D Atwell Patrick W Eiken Brendan P McMenomy Eric D Wieben Gautam Jha Rafael E Jimenez Richard Weinshilboum Liewei Wang Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy. PLoS ONE |
| title | Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy. |
| title_full | Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy. |
| title_fullStr | Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy. |
| title_full_unstemmed | Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy. |
| title_short | Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy. |
| title_sort | mutational landscapes of sequential prostate metastases and matched patient derived xenografts during enzalutamide therapy |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0145176&type=printable |
| work_keys_str_mv | AT manishkohli mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT liguowang mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT fangxie mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT huguessicotte mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT pingyin mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT scottmdehm mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT stevennhart mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT petertvedell mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT poulamibarman mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT ruiqin mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT douglaswmahoney mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT rachelecarlson mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT jeanetteeeckelpassow mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT thomasdatwell mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT patrickweiken mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT brendanpmcmenomy mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT ericdwieben mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT gautamjha mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT rafaelejimenez mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT richardweinshilboum mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy AT lieweiwang mutationallandscapesofsequentialprostatemetastasesandmatchedpatientderivedxenograftsduringenzalutamidetherapy |